| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |